These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22138262)

  • 1. Pathways and targets--opposite approaches to success?
    Blundy K
    Drug Discov Today; 2012 Mar; 17(5-6):183-4. PubMed ID: 22138262
    [No Abstract]   [Full Text] [Related]  

  • 2. New avenues to target Wnt/β-catenin signaling.
    Verkaar F; Zaman GJ
    Drug Discov Today; 2011 Jan; 16(1-2):35-41. PubMed ID: 21111060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of neurodegenerative diseases: emerging targets, treatments and technologies.
    Voss J; Ebert A; Wolfe M; Lindsley C; Cookson M; Deane R
    Future Med Chem; 2012 Sep; 4(13):1661-9. PubMed ID: 22924504
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeted drug development for arthritis.
    Malemud CJ
    Future Med Chem; 2012 Apr; 4(6):701-3. PubMed ID: 22530633
    [No Abstract]   [Full Text] [Related]  

  • 5. Multi-targeted hybrids based on HDAC inhibitors for anti-cancer drug discovery.
    Seo SY
    Arch Pharm Res; 2012 Feb; 35(2):197-200. PubMed ID: 22370774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting survivin in cancer: the cell-signalling perspective.
    Kanwar JR; Kamalapuram SK; Kanwar RK
    Drug Discov Today; 2011 Jun; 16(11-12):485-94. PubMed ID: 21511051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking the mTOR pathway: a drug discovery perspective.
    Garcia-Echeverria C
    Biochem Soc Trans; 2011 Apr; 39(2):451-5. PubMed ID: 21428918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising targets and drugs in development for colorectal cancer.
    Thompson C; Leong S; Messersmith W
    Semin Oncol; 2011 Aug; 38(4):588-97. PubMed ID: 21810518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Q&A: Ashok Venkitaraman on "undruggable" targets. Interview by Eric Bender.
    Venkitaraman A
    Cancer Discov; 2013 Jun; 3(6):597. PubMed ID: 23749513
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenotypic vs. target-based drug discovery for first-in-class medicines.
    Swinney DC
    Clin Pharmacol Ther; 2013 Apr; 93(4):299-301. PubMed ID: 23511784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exploiting functional dependencies in cancer cells for the development of targeted therapies].
    Stolze B; Scholl C
    Dtsch Med Wochenschr; 2013 Jun; 138(25-26):1369-72. PubMed ID: 23761060
    [No Abstract]   [Full Text] [Related]  

  • 13. Perspective on the pipeline of drugs being developed with modulation of DNA damage as a target.
    Plummer R
    Clin Cancer Res; 2010 Sep; 16(18):4527-31. PubMed ID: 20823148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular chaperones as therapeutic targets to counteract proteostasis defects.
    Cattaneo M; Dominici R; Cardano M; Diaferia G; Rovida E; Biunno I
    J Cell Physiol; 2012 Mar; 227(3):1226-34. PubMed ID: 21618531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of cellular signaling targets: designs and limitations.
    Vlahos CJ; Stancato LF
    Methods Mol Biol; 2004; 273():87-102. PubMed ID: 15308795
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial overview: cancer: from target discovery to targeted therapy: the risky business of target validation.
    Cruzalegui F
    Curr Opin Pharmacol; 2014 Aug; 17():iv-vi. PubMed ID: 25220882
    [No Abstract]   [Full Text] [Related]  

  • 17. The biological framework: translational research from bench to clinic.
    Yarden Y
    Oncologist; 2011; 16 Suppl 1():23-9. PubMed ID: 21278438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [mTOR complexes -- molecular spiders in molecular networks].
    Kopper L; Tímár J
    Magy Onkol; 2011 Nov; 55(4):287-94. PubMed ID: 22128312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network pharmacology for cancer drug discovery: are we there yet?
    Azmi AS
    Future Med Chem; 2012 May; 4(8):939-41. PubMed ID: 22650234
    [No Abstract]   [Full Text] [Related]  

  • 20. Overview.
    Prudhomme M
    Anticancer Agents Med Chem; 2017; 17(1):2. PubMed ID: 28143383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.